Imperial College Healthcare NHS Trust
imperial.nhs.ukTotal trials
78
Active
9
Phase 3
1
Total enrollment
158,316
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 1 of 1 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Salmonella Typhimurium | — | — | — | — | — | 1 |
Next readouts
- 2026-02-28
Top conditions
- Covid193
- Blood Pressure3
- Tuberculosis2
- Anesthesia2
- Peripheral Arterial Disease2
- Peripheral Artery Disease2
- Hypoactive Sexual Desire Disorder2
- Lung Cancer2
Frequently asked questions about Imperial College Healthcare NHS Trust
- How many clinical trials does Imperial College Healthcare NHS Trust have on ClinicalTrials.gov?
- Imperial College Healthcare NHS Trust is listed as the lead sponsor on 78 clinical trials in ClinicalTrials.gov, 9 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Imperial College Healthcare NHS Trust's trials are in Phase 3?
- 1 of Imperial College Healthcare NHS Trust's trials are in Phase 3, spread across 1 active drug program.
- What therapeutic areas does Imperial College Healthcare NHS Trust focus on?
- Imperial College Healthcare NHS Trust's most-studied conditions on ClinicalTrials.gov are Covid19, Blood Pressure, Tuberculosis, Anesthesia, Peripheral Arterial Disease.
- When are Imperial College Healthcare NHS Trust's next clinical trial readouts?
- Imperial College Healthcare NHS Trust has 1 upcoming primary-completion readout tracked here; the soonest is “Challenge Non-Typhoidal Salmonella (CHANTS) Study”, expected around 2026-02-28.